Journal article
Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events
Abstract
BACKGROUND: We studied whether aspirin resistance, defined as failure of suppression of thromboxane generation, increases the risk of cardiovascular events in a high-risk population.
METHODS AND RESULTS: Baseline urine samples were obtained from 5529 Canadian patients enrolled in the Heart Outcomes Prevention Evaluation (HOPE) Study. Using a nested case-control design, we measured urinary 11-dehydro thromboxane B2 levels, a marker of in vivo …
Authors
Eikelboom JW; Hirsh J; Weitz JI; Johnston M; Yi Q; Yusuf S
Journal
Circulation, Vol. 105, No. 14, pp. 1650–1655
Publisher
Wolters Kluwer
Publication Date
April 9, 2002
DOI
10.1161/01.cir.0000013777.21160.07
ISSN
0009-7322
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
AgedAngiotensin-Converting Enzyme InhibitorsAspirinCanadaCardiovascular DiseasesCase-Control StudiesCohort StudiesComorbidityCyclooxygenase InhibitorsDeath, Sudden, CardiacDemographyFemaleFollow-Up StudiesHumansMaleMyocardial InfarctionOdds RatioRandomized Controlled Trials as TopicRisk AssessmentRisk FactorsSecondary PreventionStrokeThromboxane B2ThromboxanesVitamin E